Colon Cancer: Diagnosis, Multidisciplinary Treatment, and Robotic Surgical Care

Colon cancer care begins with accurate diagnosis, precise staging, and coordinated multidisciplinary planning. Modern treatment integrates oncologic surgery, systemic therapy, high-resolution imaging, and molecular tumor profiling to guide individualized treatment strategies.

As a fellowship-trained robotic surgical oncologist specializing in complex gastrointestinal and hepatopancreatobiliary (HPB) cancers, Dr. Geoffrey W. Krampitz provides comprehensive surgical management of colon cancer, including robotic colectomy, multidisciplinary treatment sequencing, and integrated management of colorectal liver metastases (CRLM) when present.

Care is delivered within a multidisciplinary cancer program integrating surgical oncology, medical oncology, gastroenterology, radiology, pathology, and specialized supportive care services.

Understanding Colon Cancer

The colon (large intestine) absorbs water and processes digestive waste. Most colon cancers arise from precancerous adenomatous polyps that gradually accumulate genetic mutations over time.

Although colon and rectal cancers are often grouped together as colorectal cancer, they differ significantly in:

  • anatomy

  • surgical technique

  • treatment sequencing

Colon cancer arises within the abdominal cavity, while rectal cancer occurs within the pelvis and follows a different multidisciplinary treatment pathway.

When detected early, colon cancer is often highly treatable with surgery and appropriate systemic therapy.

Common Symptoms of Colon Cancer

Some patients with colon cancer experience few or no symptoms, which is why screening colonoscopy is critical.

Possible symptoms include:

  • changes in bowel habits (diarrhea or constipation)

  • blood in the stool or dark stools

  • abdominal discomfort or cramping

  • unexplained iron deficiency anemia

  • unintended weight loss

  • fatigue

Persistent gastrointestinal symptoms should prompt careful medical evaluation.

How Colon Cancer Is Diagnosed and Evaluated

A structured evaluation confirms the diagnosis and determines the extent of disease.

Colonoscopy and Biopsy

Colonoscopy allows direct visualization of the tumor and biopsy to confirm the diagnosis.

This examination also identifies additional polyps or synchronous lesions elsewhere in the colon.

Imaging for Staging

Imaging is used to determine whether cancer has spread beyond the colon.

Typical studies include:

  • CT scan of the chest, abdomen, and pelvis

  • MRI in selected cases

  • PET scan when clinically indicated

Imaging evaluates:

  • tumor extent

  • lymph node involvement

  • distant metastases

Because the liver is the most common site of colon cancer spread, careful hepatic evaluation is an essential component of staging.

Molecular and Precision Testing in Colon Cancer

Modern colon cancer treatment increasingly incorporates tumor biology and molecular profiling into clinical decision-making.

Testing typically includes:

  • Mismatch repair (MMR) status

  • Microsatellite instability (MSI-H)

  • KRAS and NRAS mutations

  • BRAF mutation status

  • selected cases: expanded genomic profiling

Why Molecular Testing Matters

These biomarkers influence treatment decisions and prognosis.

For example:

  • dMMR / MSI-H tumors may respond to immunotherapy

  • RAS and BRAF mutations influence systemic therapy selection

  • molecular findings may guide adjuvant therapy decisions and long-term surveillance

Molecular results are reviewed within a multidisciplinary framework to align surgical and systemic treatment strategies.

Staging of Colon Cancer

Cancer staging describes:

  • depth of tumor invasion into the colon wall

  • regional lymph node involvement

  • presence of distant metastatic disease

Treatment recommendations are determined by tumor stage, molecular biology, and overall patient health.

Treatment With Curative Intent

For most patients without distant metastases, treatment begins with surgical resection of the primary tumor.

When metastatic disease is present — particularly within the liver — treatment sequencing becomes more complex and often requires coordinated hepatopancreatobiliary (HPB) expertise.

Surgery (Oncologic Colectomy)

Colectomy removes:

  • the segment of colon containing the tumor

  • the associated blood supply

  • the regional lymph nodes

The remaining bowel is then reconnected to restore digestive continuity.

Key oncologic principles include:

  • complete tumor removal with negative margins

  • adequate lymph node harvest for staging

  • oncologically sound vascular ligation

Current standards recommend evaluation of at least 12 lymph nodes to ensure accurate pathologic staging.

Robotic and Minimally Invasive Colon Surgery

Many colon cancers can be treated using robotic-assisted or minimally invasive techniques in appropriately selected patients.

Robotic platforms provide:

  • high-definition three-dimensional visualization

  • articulated instrumentation for precise dissection

  • improved control during mesenteric vascular ligation

  • stable mesocolic plane dissection

In experienced centers, minimally invasive colectomy may:

  • reduce postoperative pain

  • shorten hospital stay

  • lower wound complication risk

  • support faster recovery

Importantly, oncologic integrity always takes precedence over operative modality.

Additional information regarding surgical philosophy is available on the Robotic Surgery page.

Management of Colon Cancer with Liver Metastases (CRLM)

The liver is the most common site of colon cancer metastasis.

When colorectal liver metastases are present, treatment may involve coordinated strategies including:

  • preoperative systemic therapy

  • colon-first approach

  • liver-first strategy

  • simultaneous colon and liver resection in selected patients

  • staged hepatectomy for complex disease

Advanced techniques such as parenchymal-sparing liver surgery and robotic liver resection may be used in carefully selected cases.

As an HPB-focused surgical oncologist, Dr. Krampitz integrates management of colon cancer and liver metastases within a unified treatment strategy to optimize both oncologic control and preservation of liver function.

More information is available on the Colorectal Liver Metastases (CRLM) page.

Systemic Therapy

Chemotherapy may be recommended:

  • after surgery (adjuvant therapy)

  • before surgery in selected high-risk cases

  • as primary therapy in metastatic disease

Treatment regimens are selected based on tumor stage, molecular profile, and multidisciplinary consensus.

Immunotherapy (Selected Patients)

Patients with dMMR / MSI-high tumors may benefit from immune checkpoint inhibitor therapy.

These decisions are made collaboratively with medical oncology specialists.

Potential Risks After Surgery

Colon surgery is a major abdominal operation and requires careful postoperative monitoring.

Possible complications include:

  • bleeding

  • infection

  • anastomotic leak

  • temporary bowel dysfunction

  • blood clots or pneumonia

Most complications are manageable when recognized early.

Enhanced Recovery After Surgery (ERAS) protocols are used to support safe and efficient recovery.

Recovery After Colon Surgery

Recovery depends on several factors, including:

  • surgical approach

  • tumor stage

  • patient health conditions

Patients receive personalized postoperative guidance, nutritional support, and structured surveillance planning.

Additional recovery information is available in the Patient Resources section.

Multidisciplinary Colon Cancer Care

Optimal colon cancer care requires collaboration among multiple specialists, including:

  • surgical oncology

  • medical oncology

  • gastroenterology

  • radiology and pathology

  • hepatopancreatobiliary surgery when liver metastases are present

  • nutrition and supportive services

Treatment sequencing is individualized to align tumor biology with surgical timing and systemic therapy strategy.

Summary

Colon cancer treatment is highly effective when guided by:

  • precise staging

  • molecular tumor profiling

  • multidisciplinary coordination

  • experienced oncologic surgery

When liver metastases are present, integrated hepatopancreatobiliary expertise is essential to optimize outcomes.

Advances in robotic surgical technique, systemic therapy, and precision oncology continue to improve survival while preserving quality of life.

Consultation and Referral

For Patients
Individuals seeking evaluation or a second opinion for colon cancer may Request a Consultation to discuss individualized treatment strategies.

For Referring Physicians
Physicians wishing to refer a patient or discuss complex colorectal malignancies may visit For Physicians for coordinated referral pathways and multidisciplinary case review.